New President at Transition Therapeutics (NASDAQ:TTHI) | Seeking Alpha

Healthcare

,

Transition Therapeutics (TTHI +0.1%) promotes Chief Operating Officer Carl Damiani to President. He joined the firm in 2003 as Director of Business Development.

This was corrected on 02/04/2019 at 4:40 PM. Name corrected.

Recommended For You

Related Stocks

Symbol	Last Price	% Chg
TTHI	-	-
Transition Therapeutics, Inc.